Clinical Trials Browser

Phase 1 × emactuzumab × Tumor-Agnostic × Clear all

NCT02760797 2018-05-22

A Study of Emactuzumab and RO7009789 Administered in Combination in Participants With Advanced Solid Tumors

Phase 1 Completed

Neoplasms